New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market
SponsoredMedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care
SponsoredBioSig Technologies Inc. Reports Increased Adoption of its Signal Processing Technology for Arrhythmia Care
SponsoredBioSig's PURE EP Aims to Address Unmet Needs of Afib Patients
SponsoredBioSig Technologies Recent News
BioSig Expands in Electrophysiology with St. Elizabeth's Medical Center Evaluation
Sponsored
Mayo Clinic Purchases BioSig's PURE EP™ for use at its Phoenix Location
Sponsored
BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology
Sponsored
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
Sponsored
BioSig Technologies Achieves First Commercial Sale Of Its PURE EP System
Sponsored